暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
Nemaura Medical 重组财务,董事会成员变动
TipRanks04/10 16:33 (美东)
Alzamend Neuro和其他3只低于3美元的股票内部人士正在买入
150 万美元押注这只医疗保健股?看看这4只细价股内部人士正在积极买入道琼斯指数周二收盘下跌超过150点。当内部人士购买或出售股票时
Benzinga01/10 08:09 (美东)
原油涨幅超过3%;美国制造业活动连续第14个月收缩
美国股市在交易中途走低,纳斯达克综合指数周三下跌约150点。道琼斯指数下跌0.79%,至37,417.28点,而纳斯达克指数下跌1.01%,至14,616.58点。这个
Benzinga01/03 12:01 (美东)
道琼斯指数在美联储会议纪要公布前下跌超过100点;第一季度业绩公布后,UniFirst股价下跌
美国股市今天上午走低,道琼斯指数周三下跌超过100点。周三开盘后,道琼斯指数下跌0.35%,至37,584.32,而纳斯达克指数
Benzinga01/03 09:55 (美东)
Nemaura Medical的董事会和管理团队已做出战略决定,接受纳斯达克将Nemaura Medical退市并进入场外交易市场的决定
Nemaura Medical的董事会和管理团队已做出战略决定,接受纳斯达克将Nemaura Medical退市并进入场外交易市场的决定
Benzinga01/03 07:12 (美东)
有关上市状况和战略方向的重要更新
2024年1月3日关于上市状况和战略方向的重要更新英国拉夫堡,2024年1月3日(GLOBE NEWSWIRE)——Nemaura Medical Inc.(“Nemaura Medical” 或 “公司”),广告开发商
Nemaura Medical01/03 00:00 (美东)
Massinooo : Nemaura Medical (NASDAQ:NMRD) they reported a loss
Massinooo : Any clinical trials approvals?
Trytosaveabit楼主 Massinooo: They reported a mix! Some good some not so good!
Trytosaveabit楼主 Massinooo: Their new product is approved in Saudi! And they are waiting to hear from the FDA on the approval of their PMA on their sugarBEAT non invasive CGM! I think in the USA it will be a game changer in the weight loss and Diabetes market!
Massinooo Trytosaveabit楼主: Nice! We’ll keep an eye on it. Is there any big trials results announcement for today? I mean any company?
Den the Dragon : mmhhh up and down....
never walk alone0727 :
hi good morning how are you@AmyNic
still can go in
I Love Edgy Waifus : You entering this?
AmyNic楼主 : I'm just watching right now
Riding Star :
Good morning to US
Good evening to SG
暂无数据
暂无数据
diligent Lark_7825 : when delist?